TROG Cancer Research
Members Login   CQMS Login

TROG Annual Scientific Meeting 

Register now for the 2020 Annual Scientific Meeting at the
International Convention Centre, Sydney from 16-19 March 2020

The 2020 Annual Scientific Meeting (ASM) will host a number of international and national renowned keynote speakers alongside key TROG cancer researchers and clinicians. More than 300 delegates attend our meeting including leading Australian and New Zealand Radiation Oncologists, Radiation Therapists, Interventional Oncologists, Medical Physicists and clinical trials personnel.

The ASM Organising Committee is developing a full and extensive program, which will include three and a half days of collaborative workshops, scientific sessions showcasing radiation oncology clinical trials, discussion of new trial concepts, future research directions and technological advancements.

Sydney is a spectacular host city for the ASM, boasting an iconic harbour, bridge, cultural venues, international cuisine and surf beaches. More importantly, Sydney is a truly cosmopolitan city, with a rich diversity of peoples from all around the world who call it their home. Sydney’s stunning coastal setting and convenient international and national transport linkages provide an attractive and accessible venue to host the 2020 ASM. The Sydney International Convention Centre will host the ASM, and is located on the harbour foreshore, in the heart of the city centre.

The Organising Committee looks forward to welcoming all delegates to Sydney.

Dr Puma Sundaresan - TROG 2020 ASM Co-Convenor

Ms Jo Page - TROG 2020 ASM Co-Convenor


Find More ASM Information HERE

Find More Workshop Information HERE

Watch our video to see what our Annual Scientific Meeting (ASM) is all about. Watch the highlights video from the TROG 2018 ASM which was held in Hobart, Tasmania.

If you need access to presentations from prior meetings, please contact the TROG Central Operations Office on +61 2 4014 3911 or via email on 

Stay up to date with our TROG 2020 ASM!

* indicates required


Thank you to the 100+ trial sites who support our clinical trials worldwide.

Latest News

  • 10 Dec 2020

    An international study (BIG 3-07/TROG 07.01) shows that after breast conserving surgery, higher radiation doses to the part of the breast where the DCIS was found, in addition to radiotherapy of the whole breast, significantly reduced its risk of returning in patients with higher-risk DCIS.

  • 15 May 2020

    The diagnosis of ductal carcinoma in situ (DCIS) of the breast has increased substantially due to mammographic screening, and now accounts for 25 per cent of screen-detected breast cancer. Over 1,600 women are diagnosed with DCIS in Australia every year. However, unlike invasive breast cancer, there are limited knowledge and experience for patients and clinicians to draw on when this now common diagnosis of DCIS is made.

  • 15 Apr 2020

    Prostate cancer is one of the most common cancers amongst men, with one in six men diagnosed before their 85th birthday (Cancer Australia). In fact, in 2019 alone over 19,000 men in Australia were diagnosed with prostate cancer.

  • 06 Apr 2020

    p style="text-align: center;">_ src="/sitefiles/trogcomau/trog_team_2020.jpg" style="height: 333px; width: 500px;" />   covid-19 and the regulations around social distancing has affected an increasing number of events across australia, including the yearly gathering of radiation...

  • 01 Apr 2020

    The coronavirus health pandemic is a challenging time for us all – personally and professionally. We know that the changes and safety precautions required as a result of the pandemic have had significant impacts on the way we operate clinical trials – those that are underway, set t...

  • 15 Jan 2020

    _ src="/sitefiles/trogcomau/fbp_0378_large.jpg" /> new research by the university of new south wales (unsw), presented at the clinical oncology society of australia’s (cosa) annual scientific meeting (asm) found that increased use of radiation therapy for prostate cancer patients c...

  • 13 Sep 2019

    trog cancer research will work with clinicians at townsville hospital, as well as other national experts, to implement a research program aimed at understanding how to best use new mri linac technology to benefit cancer patients. img src="/sitefiles/trogcomau/tro_trog_cancer_resear...

  • 09 Sep 2019

    TROG Cancer Research is currently in the final year of their 2017-2019 strategic plan. On Friday 2 August 2019, we held a strategic planning meeting with key stakeholders to discuss the direction and focus for the upcoming three years.  The workshop facilitated by Ms Alison Evans, Hea...

  • 03 Sep 2019

    trog cancer research are proud to announce that we have two new additions to the trog cancer research board of directors. joining our team is professor annette haworth and denis byron. appointed as a non-radiation oncology director, annette is an accredited medical physicist wh...